Abstract
Although preeclampsia (PE) is one of the most important problems affecting pregnant women, etiologic factors in its development are still unclear. We aimed to investigate the expression levels of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) in preeclamptic and control healthy placentas. Placental tissue samples were obtained after delivery from patients diagnosed with PE, and from normal term pregnants and analyzed by immunohistochemistry for the expression levels of the two adhesion molecules PECAM-1 and ICAM-1. A strong expression of PECAM-1 in endothelial cells lining the vessel walls of placental villi in placentas of control group was found, but the intensity of PECAM-1 expression was highly reduced in placentas of PE group (p = 0.017). Conversely, a strong expression of ICAM-1 was observed in placental villi in PE, significantly higher than that of normal placentas (p = 0.005). The findings of a decrease of PECAM-1 expression and an increase of ICAM-1 expression in preeclamptic placenta suggest the existence of functional roles of these adhesion molecules in the pathophysiology of PE, probably by contributing to the reduced trophoblast invasion and the increased vascular damage, respectively. Inhibiting ICAM-1 (i.e., with ICAM-1 monoclonal antibody) and promoting PECAM-1 expression may be good therapeutic approaches to prevent PE symptoms in the future.
Similar content being viewed by others
References
G.A. Dekker, H.P. van Geijn, Endothelial dysfunction in preeclampsia. I: primary prevention. Therapeutic perspectives. J. Perinat. Med. 24, 119–139 (1996)
I. Brosens, W.B. Robertson, H.G. Dixon, The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93, 569–579 (1967)
R. Pijnenborg, J.M. Bland, W.B. Robertson, I. Brosens, Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4, 397–413 (1983)
J. Nasiell, H. Nisell, A. Blanck, N.O. Lunell, M. Faxen, Placental expression of endothelial constitutive nitric oxide synthase mRNA in pregnancy complicated by preeclampsia. Acta Obstet. Gynecol. Scand. 77, 492–496 (1998)
A.T. Papageorghiou, C.K. Yu, R. Bindra, G. Pandis, K.H. Nicolaides, Fetal Medicine Foundation Second Trimester Screening Group. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet. Gynecol. 18, 441–449 (2001)
A.T. Papageorghiou, C.K. Yu, S. Cicero, S. Bower, K.H. Nicolaides, Second-trimester uterine artery Doppler screening in unselected populations: a review. J. Matern. Fetal Neonatal Med. 12, 78–88 (2002)
S. Di Paolo, P. Volpe, G. Grandaliano, G. Stallone, A. Schena, P. Greco et al., Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J. Nephrol. 16, 650–657 (2003)
R. Pijnenborg, J. Anthony, D.A. Davey, A. Rees, A. Tiltman, L. Vercruysse et al., Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 98, 648–655 (1991)
L. Myatt, M. Miodovnik, Prediction of preeclampsia. Semin. Perinatol. 23, 45–57 (1999)
R.N. Sammour, F.M. Nakhoul, A.P. Levy, R. Miller-Lotan, N. Nakhoul, H.R. Awad et al., Haptoglobin phenotype in women with preeclampsia. Endocrine 38, 303–308 (2010)
W.B. Robertson, I. Brosens, H.G. Dixon, The pathological response of the vessels of the placental bed to hypertensive pregnancy. J. Path. Bact. 93, 581–592 (1967)
I.A. Greer, Pathological processes in pregnancy-induced hypertention and intrauterine growth retardation: ‘‘an excess of heated blood’’, in Haemost Thromb Obstet Gynecol, ed. by I.A. Greer, A.G.G. Turpie, C.D. Forbes (Chapman and Hall, London, 1992), pp. 163–202
J.M. Harlan, Neutrophil-mediated vascular injury. Acta Med. Scand. Suppl. 715, 123–129 (1987)
Y. Zhou, C.H. Damsky, K. Chiu, J. Roberts, S. Fisher, Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J. Clin. Invest. 91, 950–960 (1993)
P.B. Juliano, M.H. Blotta, A.M. Altemani, ICAM-1 is overexpressed by villous trophoblasts in placentitis. Placenta 27, 750–757 (2006)
T.A. Springer, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301–314 (1994)
A. Scheynius, R.L. Camp, E. Puré, Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J. Immunol. 150, 655–663 (1993)
M.E. Anderson, T.J. Siahaan, Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides 24, 487–501 (2003)
B.J. Masten, J.L. Yates, A.M. Pollard Koga, M.F. Lipscomb, Characterization of accessory molecules in murine lung dendritic cell function: roles for CD80, CD86, CD54, and CD40L. Am. J. Respir. Cell Mol. Biol. 16, 335–342 (1997)
P.J. Newman, M.C. Berndt, J. Gorski, G.C. White 2nd, S. Lyman, C. Paddock et al., PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247, 1219–1222 (1990)
P.J. Newman, The biology of PECAM-1. J. Clin. Invest. 99, 3–8 (1997)
W.H. Sun, Y.L. Sun, R.N. Fang, Y. Shao, H.C. Xu, Q.P. Xue et al., Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn. J. Clin. Oncol. 35, 707–713 (2005)
C. Tokyol, F. Aktepe, F.H. Dilek, O. Sahin, D.T. Arioz, Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int. J. Gynecol. Pathol. 28, 148–156 (2009)
A.Y. Goksu Erol, M. Nazli, S. Elis Yildiz, Expression levels of cyclooxygenase-2, tumor necrosis factor-α and inducible NO synthase in placental tissue of normal and preeclamptic pregnancies. J. Matern. Fetal Neonatal Med. (2011). doi:10.3109/14767058.2011.595853
E. Abe, K. Matsubara, K. Oka, Y. Kusanagi, M. Ito, Cytokine regulation of intercellular adhesion molecule-1 expression on trophoblasts in preeclampsia. Gynecol. Obstet. Invest. 66, 27–33 (2008)
J.R. Wilczyński, M. Banasik, H. Tchórzewski, E. Głowacka, A. Malinowski, M. Szpakowski et al., Expression of intercellular adhesion molecule-1 on the surface of peripheral blood and decidual lymphocytes of women with pregnancy-induced hypertension. Eur. J. Obstet. Gynecol. Reprod. Biol. 102, 15–20 (2002)
D. Aliefendioğlu, G. Erdem, N. Tülek, M. Yurdakök, Neonatal and maternal serum levels of soluble ICAM-1 in preeclamptic and normal pregnancies. Am. J. Perinatol. 19, 333–339 (2002)
S.Y. Kim, H.M. Ryu, J.H. Yang, M.Y. Kim, H.K. Ahn, H.J. Lim et al., Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J. Korean Med. Sci. 19, 688–692 (2004)
A. Szarka, J. Rigó Jr, L. Lázár, G. Beko, A. Molvarec, Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2(11), 59 (2010)
Z. Wang, H. Zou, Y. Yu, Y. Song, Monoclonal antibody to intercellular adhesion molecule-1 as a novel therapy for preeclampsia: preliminary results from a rat model. J. Matern. Fetal Neonatal Med. (2011). doi:10.3109/14767058.2011.599077
J. Tziotis, A. Malamitsi-Puchner, G. Vlachos, G. Creatsas, S. Michalas, Adhesion molecules expression in the placental bed of pregnancies with pre-eclampsia. BJOG 109, 197–201 (2002)
K. Jaakkola, V. Jokimaa, M. Kallajoki, S. Jalkanen, E. Ekholm, Pre-eclampsia does not change the adhesion molecule status in the placental bed. Placenta 21, 133–141 (2000)
F. Lyall, I.A. Greer, F. Boswell, A. Young, L.M. Macara, M.D. Jeffers, Expression of cell adhesion molecules in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth retardation. Placenta 16, 579–587 (1995)
S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, S. Mondal et al., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649–658 (2003)
S. Venkatesha, M. Toporsian, C. Lam, J. Hanai, T. Mammoto, Y.M. Kim et al., Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642–649 (2006)
J.P. Granger, B.T. Alexander, M.T. Llinas, W.A. Bennett, R.A. Khalil, Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9, 147–160 (2002)
Y. Zhou, M. McMaster, K. Woo, M. Janatpour, J. Perry, T. Karpanen et al., Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am. J. Pathol. 160, 1405–1423 (2002)
S. Helske, P. Vuorela, O. Carpen, C. Hornig, H. Weich, E. Halmesmaki, Expression of vascular endothelial growth factor receptors 1, 2, and 3 in placentas from normal and complicated pregnancies. Mol. Hum. Reprod. 7, 205–210 (2001)
R. Thadhani, W.P. Mutter, M. Wolf, R.J. Levine, R.N. Taylor, V.P. Sukhatme et al., First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J. Clin. Endocrinol. Metab. 89, 770–775 (2004)
L. Anton, D.C. Merrill, L.A. Neves, C. Gruver, C. Moorefield, K.B. Brosnihan, Angiotensin II and angiotensin-(1–7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study. Reprod. Biol. Endocrinol. 4(8), 135 (2010)
F. Lyall, J.N. Bulmer, E. Duffie, F. Cousins, A. Theriault, S.C. Robson, Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am. J. Pathol. 158, 1713–1721 (2001)
B. Sontia, R.M. Touyz, Role of magnesium in hypertension. Arch. Biochem. Biophys. 458, 33–39 (2007)
K. Skajaa, A. Forman, K.E. Andersson, Effects of magnesium on isolated human fetal and maternal uteroplacental vessels. Acta Physiol. Scand. 139, 551–559 (1990)
M. Cervar, D.M. Nelson, F. Kainer, G. Desoye, Drug actions in preeclampsia: aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion. Am. J. Obstet. Gynecol. 176, 66–72 (1997)
A. Amash, A.Y. Weintraub, E. Sheiner, A. Zeadna, M. Huleihel, G. Holcberg, Possible therapeutic effect of magnesium sulfate in pre-eclampsia by the down-regulation of placental tumor necrosis factor-alpha secretion. Eur. Cytokine Netw. 21, 58–64 (2010)
X. Xiong, N.N. Demianczuk, L.D. Saunders, F.L. Wang, W.D. Fraser, Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am. J. Epidemiol. 1(155), 203–209 (2002)
Conflict of interest
The authors report no declarations of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goksu Erol, A.Y., Nazli, M. & Elis Yildiz, S. Significance of platelet endothelial cell adhesion molecule-1 (PECAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in preeclamptic placentae. Endocrine 42, 125–131 (2012). https://doi.org/10.1007/s12020-012-9644-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9644-9